Nathan Lawrence insider trades: Pressure Biosciences (PBIO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nathan reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 19, 2018 | PBIO | ↑ Buy | 1,000 | $2.00 | $2K | Direct | Dec 19, 2018 (0d) |
| Nov 20, 2006 | PBIO | ↑ Buy | 500 | $3.18 | $2K | Direct | Nov 21, 2006 (1d) |
| Sep 7, 2006 | PBIO | ↑ Buy | 1,000 | $3.14 | $3K | Direct | Sep 7, 2006 (0d) |
| Aug 28, 2006 | PBIO | ↑ Buy | 400 | $2.96 | $1K | Direct | Aug 29, 2006 (1d) |
| Jul 19, 2006 | PBIO | ↑ Buy | 2,000 | $3.27 | $7K | Direct | Jul 21, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Nathan Lawrence's insider trades
Nathan Lawrence is VP of Marketing & Sales at Pressure Biosciences (PBIO). Since Jul 19, 2006, Nathan has reported 5 open-market purchases worth $14K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), other transactions (9 filings), shares returned to the company (6 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.